Related Experiment Video
Updated: Dec 8, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary
Sophia L Song1, Sarah B Hays1, Constance E Panton1
1Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Insights
This study found that statin use was associated with a lower risk of invasive mechanical ventilation in hospitalized COVID-19 patients. These findings support the continued use of statins for managing COVID-19 patients with cardiovascular disease.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- COVID-19 severity is increased in patients with cardiovascular disease (CVD).
- Statins, prescribed for CVD, possess anti-inflammatory and immunomodulatory properties.
- The impact of statins on COVID-19 outcomes requires further investigation.
Purpose of the Study:
- To explore the association between statin use and severe COVID-19 outcomes.
- To analyze the relationship between statin use and intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and in-hospital death.
Main Methods:
- Retrospective cohort study of 249 hospitalized COVID-19 patients.
- Data collected: demographics, medical history, medications, hospital course.
- Multivariate logistic regression analysis adjusted for key covariates.
Main Results:
- Statin use was significantly associated with a decreased risk of IMV (aOR = 0.45, 95% CI: 0.20-0.99) after adjustment.
- No significant association was found for ICU admission or in-hospital death.
Conclusions:
- Findings suggest statin use may reduce the need for IMV in hospitalized COVID-19 patients.
- Results support the continued use of statins in COVID-19 patients.
- Further prospective studies are warranted to confirm these findings and guide management strategies.
Abstract:
COVID-19 disproportionately affects patients with medical comorbidities such as cardiovascular disease (CVD). Patients with CVD are widely prescribed 3-hydroxy-3-methyl-glutayl-CoA (HMG-CoA) reductase inhibitors (statins), a class of lipid-lowering medications known for their pleiotropic anti-inflammatory and immunomodulatory effects. However, the relationship between statin use and COVID-19 outcomes is not fully understood. In this preliminary study, we explored the association between statin use and severe COVID-19 outcomes in hospitalized patients, including intensive care unit (ICU) admission, the need for invasive mechanical ventilation (IMV), and in-hospital death. We performed a retrospective cohort study of 249 patients hospitalized with COVID-19 from 3 March 2020 to 10 April 2020 in Rhode Island, USA. Patient demographics, past medical history, current medications, and hospital course were recorded and analyzed. A multivariate logistic regression analysis was conducted to examine associations. After adjusting for age, sex, race, cardiovascular disease, chronic pulmonary disease, diabetes, and obesity, statin use was significantly associated with decreased risk for IMV (adjusted Odds Ratio (aOR) = 0.45, 95% Confidence Interval (CI): 0.20-0.99). Our results support the continued use of statins among COVID-19 patients and could have implications for future prospective studies on the management of COVID-19.
More Related Videos
Related Concept Videos
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Myocarditis III: Medical Management
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Acute Coronary Syndrome IV: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Mitral Stenosis III: Medical Management

